Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024
March 05, 2024 16:01 ET
|
Bionano Genomics
Q4 2023 revenue was $10.7 million, which represents a 30% increase over Q4 2022FY 2023 revenue was $36.1 million, which represents a 30% increase over FY 2022Reached installed base of 326 optical...
Bionano to Present at TD Cowen’s 44th Annual Health Care Conference
February 29, 2024 08:00 ET
|
Bionano Genomics
SAN DIEGO, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at TD Cowen’s...
Bionano to Report Fourth Quarter and Year End 2023 Financial Results and Host a Conference Call and Webcast on March 5, 2024
February 28, 2024 08:01 ET
|
Bionano Genomics
SAN DIEGO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Tuesday, March 5, 2024, at 4:30 p.m....
Bionano Announces Amendment to Debt Financing Arrangement to Extend Cash Runway
February 28, 2024 08:00 ET
|
Bionano Genomics
SAN DIEGO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (“Bionano”) (Nasdaq: BNGO) today announced that is has amended the convertible debt financing the company entered into in October...
American College of Medical Genetics and Genomics Includes OGM in Latest Edition of Technical Laboratory Standards for Solid Tumor Analysis
February 22, 2024 08:00 ET
|
Bionano Genomics
SAN DIEGO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced that optical genome mapping (OGM) was included for the first time in the American College of...
Bionano to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference
January 31, 2024 08:00 ET
|
Bionano Genomics
SAN DIEGO, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will participate in the...
Bionano’s Symposium 2024 Featured Presentations from its Global User Community Highlighting OGM as a Powerful Alternative to Classical Cytogenetics and Strong Complement to NGS
January 30, 2024 08:00 ET
|
Bionano Genomics
Over 2,100 registrants with attendees from 92 countriesAverage daily attendance of 574 32 oral presentations delivered across four consecutive days69 scientific posters featuring optical genome...
Bionano Announces Publication of a Study that Applied OGM to Discovery of Structural Variants Driving Drug Resistance and Sensitivity in Cancer
January 25, 2024 08:00 ET
|
Bionano Genomics
SAN DIEGO, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a peer-reviewed publication in Cancers from a team of cancer researchers primarily at the...
Bionano Announces Publication of Interim Readout from Second Phase of Clinical Trial Analyzing Optical Genome Mapping as Standard of Care (SOC) for Prenatal Testing
January 24, 2024 08:00 ET
|
Bionano Genomics
Pre-print publication from Levy, et al. describes the second phase of a multisite evaluation and validation of optical genome mapping (OGM) that is designed to measure the workflow’s accuracy and...
Bionano Announces Full Commercial Release of the Stratys™ System for High Throughput Optical Genome Mapping
January 23, 2024 08:00 ET
|
Bionano Genomics
Bionano has completed the early access program for the Stratys™ system and is now making it available in a full commercial releaseThe Stratys instrument can enable up to a four-fold increase in raw...